Antimicrobial Resistance of Clostridioides difficile in Children from a Tertiary Pediatric Hospital in Shanghai, China

References

• Martin JS, Monaghan TM, Wilcox MH. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol. 2016;13(4):206–216. doi:10.1038/nrgastro.2016.25
   PubMed Web of Science ®Google Scholar
• McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1–e48. doi:10.1093/cid/cix1085
   PubMed Web of Science ®Google Scholar
• Buddle JE, Fagan RP. Pathogenicity and virulence of Clostridioides difficile. Virulence. 2023;14(1):2150452. doi:10.1080/21505594.2022.2150452
   PubMed Web of Science ®Google Scholar
• Krutova M, de Meij TGJ, Fitzpatrick F, Drew RJ, Wilcox MH, Kuijper EJ. How to: clostridioides difficile infection in children. Clin Microbiol Infect. 2022;28(8):1085–1090. doi:10.1016/j.cmi.2022.03.001
   PubMed Web of Science ®Google Scholar
• Wolf J, Kalocsai K, Fortuny C, et al. Safety and efficacy of fidaxomicin and vancomycin in children and adolescents with clostridioides (Clostridium) difficile infection: a phase 3, multicenter, randomized, single-blind clinical trial (SUNSHINE). Clin Infect Dis. 2020;71(10):2581–2588. doi:10.1093/cid/ciz1149
   PubMed Web of Science ®Google Scholar
• Peng Z, Jin D, Kim HB, et al. Update on antimicrobial resistance in clostridium difficile: resistance mechanisms and antimicrobial susceptibility testing. J Clin Microbiol. 2017;55(7):1998–2008. doi:10.1128/JCM.02250-16
   PubMed Web of Science ®Google Scholar
• Sholeh M, Krutova M, Forouzesh M, et al. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9(1):158. doi:10.1186/s13756-020-00815-5
   PubMed Web of Science ®Google Scholar
• Zhao H, Nickle DC, Zeng Z, et al. Global landscape of clostridioides difficile phylogeography, antibiotic susceptibility, and toxin polymorphisms by post-hoc whole-genome sequencing from the MODIFY I/II studies. Infect Dis Ther. 2021;10(2):853–870. doi:10.1007/s40121-021-00426-6
   PubMed Web of Science ®Google Scholar
• Darkoh C, Keita K, Odo C, et al. Emergence of clinical clostridioides difficile isolates with decreased susceptibility to vancomycin. Clin Infect Dis. 2022;74(1):120–126. doi:10.1093/cid/ciaa912
   PubMed Web of Science ®Google Scholar
• Li X, Xiao F, Li Y, et al. Characteristics and management of children with Clostridioides difficile infection at a tertiary pediatric hospital in China. Braz J Infect Dis. 2022;26(4):102380. doi:10.1016/j.bjid.2022.102380
   PubMed Web of Science ®Google Scholar
• Boekhoud IM, Hornung BVH, Sevilla E, et al. Plasmid-mediated metronidazole resistance in Clostridioides difficile. Nat Commun. 2020;11(1):598. doi:10.1038/s41467-020-14382-1
   PubMed Web of Science ®Google Scholar
• Boekhoud IM, Sidorov I, Nooij S, et al. Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile. J Antimicrob Chemother. 2021;76(7):1731–1740. doi:10.1093/jac/dkab097
   PubMed Web of Science ®Google Scholar
• Olaitan AO, Dureja C, Youngblom MA, et al. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile. Nat Commun. 2023;14(1):4130. doi:10.1038/s41467-023-39429-x
   PubMed Web of Science ®Google Scholar
• Deshpande A, Wu X, Huo W, Palmer KL, Hurdle JG. Chromosomal resistance to metronidazole in clostridioides difficile can be mediated by epistasis between iron homeostasis and oxidoreductases. Antimicrob Agents Chemother. 2020;64(8). doi:10.1128/AAC.00415-20
   PubMed Web of Science ®Google Scholar
• Shen WJ, Deshpande A, Hevener KE, et al. Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates. J Antimicrob Chemother. 2020;75(4):859–867. doi:10.1093/jac/dkz513
   PubMed Web of Science ®Google Scholar
• Eubank TA, Gonzales-Luna AJ, Hurdle JG, Garey KW. Genetic mechanisms of vancomycin resistance in clostridioides difficile: a systematic review. Antibiotics. 2022;11(2). doi:10.3390/antibiotics11020258
   Google Scholar
• Pu M, Cho JM, Cunningham SA, et al. Plasmid acquisition alters vancomycin susceptibility in clostridioides difficile. Gastroenterology. 2021;160(3):941–945 e948. doi:10.1053/j.gastro.2020.10.046
   PubMed Web of Science ®Google Scholar
• CLSI. CaLSI: Performance Standards for Antimicrobial Susceptibility Testing. 32nd. CLSI supplement M100; 2022.
   Google Scholar
• EUCAST. Clinical breakpoints and dosing of antibiotics; 2022. Available from: https://wwweucastorg/clinical_breakpoints/. Accessed January 08, 2024.
   Google Scholar
• PubMLST. Clostridioides difficile. Available from: https://pubmlst.org/cdifficile/. Accessed January 8, 2024.
   Google Scholar
• Page AJ, Cummins CA, Hunt M, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31(22):3691–3693. doi:10.1093/bioinformatics/btv421
   PubMed Web of Science ®Google Scholar
• Emms DM, Kelly S. OrthoFinder: phylogenetic orthology inference for comparative genomics. Genome Biol. 2019;20(1):238. doi:10.1186/s13059-019-1832-y
   PubMed Web of Science ®Google Scholar
• iTOL. Interactive Tree of Life. Available from: https://itol.embl.de/itol.cgi. Accessed January 8, 2024.
   Google Scholar
• VFDB. Available from: http://www.mgc.ac.cn/VFs/main.htm. Accessed January 8, 2024.
   Google Scholar
• Resfinder. Available from: https://cge.cbs.dtu.dk/services/ResFinder. Accessed January 8, 2024.
   Google Scholar
• Jia B, Raphenya AR, Alcock B, et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 2017;45(D1):D566–D573. doi:10.1093/nar/gkw1004
   PubMed Web of Science ®Google Scholar
• Inouye M, Dashnow H, Raven LA, et al. SRST2: rapid genomic surveillance for public health and hospital microbiology labs. Genome Med. 2014;6(11):90. doi:10.1186/s13073-014-0090-6
   PubMed Web of Science ®Google Scholar
• Krutova M, Wilcox M, Kuijper E. Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view? Int J Infect Dis. 2022;124:118–123. doi:10.1016/j.ijid.2022.09.013
   PubMed Web of Science ®Google Scholar
• Nicholson MR, Mitchell PD, Alexander E, et al. Efficacy of fecal microbiota transplantation for clostridium difficile infection in children. Clin Gastroenterol Hepatol. 2020;18(3):612–619 e611. doi:10.1016/j.cgh.2019.04.037
   PubMed Web of Science ®Google Scholar
• Alvarez AM, Rathore MH. Clostridium difficile Infection in Children. Adv Pediatr. 2019;66:263–280. doi:10.1016/j.yapd.2019.03.010
   PubMedGoogle Scholar
• Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–834. doi:10.1056/NEJMoa1408913
   PubMed Web of Science ®Google Scholar
• Nicholson MR, Thomsen IP, Slaughter JC, Creech CB, Edwards KM. Novel risk factors for recurrent Clostridium difficile infection in children. J Pediatr Gastroenterol Nutr. 2015;60(1):18–22. doi:10.1097/MPG.0000000000000553
   PubMed Web of Science ®Google Scholar
• Farowski F, Solbach P, Tsakmaklis A, et al. Potential biomarkers to predict outcome of faecal microbiota transfer for recurrent Clostridioides difficile infection. Dig Liver Dis. 2019;51(7):944–951. doi:10.1016/j.dld.2019.01.012
   PubMedGoogle Scholar
• Wen X, Shen C, Xia J, et al. Whole-genome sequencing reveals the high nosocomial transmission and antimicrobial resistance of clostridioides difficile in a single center in China, a four-year retrospective study. Microbiol Spectr. 2022;10(1):e0132221. doi:10.1128/spectrum.01322-21
   PubMed Web of Science ®Google Scholar
• Xu X, Luo Y, Chen H, et al. Genomic evolution and virulence association of Clostridioides difficile sequence type 37 (ribotype 017) in China. Emerg Microbes Infect. 2021;10(1):1331–1345. doi:10.1080/22221751.2021.1943538
   PubMed Web of Science ®Google Scholar
• Gargis AS, Karlsson M, Paulick AL, et al. Reference susceptibility testing and genomic surveillance of clostridioides difficile, United States, 2012–17. Clin Infect Dis. 2023;76(5):890–896. doi:10.1093/cid/ciac817
   PubMed Web of Science ®Google Scholar
• Huang H, Weintraub A, Fang H, Wu S, Zhang Y, Nord CE. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains. Anaerobe. 2010;16(6):633–635. doi:10.1016/j.anaerobe.2010.09.002
   PubMed Web of Science ®Google Scholar
• Greentree DH, Rice LB, Donskey CJ. Houston, we have a problem: reports of clostridioides difficile isolates with reduced vancomycin susceptibility. Clin Infect Dis. 2022;75(9):1661–1664. doi:10.1093/cid/ciac444
   PubMed Web of Science ®Google Scholar
• Peltier J, Courtin P, El Meouche I, et al. Genomic and expression analysis of the vanG-like gene cluster of Clostridium difficile. Microbiology. 2013;159(Pt 7):1510–1520. doi:10.1099/mic.0.065060-0
   PubMedGoogle Scholar
• Farrow KA, Lyras D, Rood JI. Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile. Microbiology. 2001;147(Pt 10):2717–2728. doi:10.1099/00221287-147-10-2717
   PubMedGoogle Scholar
• Roberts MC. Acquired tetracycline and/or macrolide-lincosamides-streptogramin resistance in anaerobes. Anaerobe. 2003;9(2):63–69. doi:10.1016/S1075-9964(03)00058-1
   PubMed Web of Science ®Google Scholar
• Dridi L, Tankovic J, Petit JC. CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE family. Microb Drug Resist. 2004;10(3):191–196. doi:10.1089/mdr.2004.10.191
   PubMed Web of Science ®Google Scholar
• Liu J, Peng L, Su H, et al. Chromosome and plasmid features of two ST37 clostridioides difficile strains isolated in China reveal distinct multidrug resistance and virulence determinants. Microb Drug Resist. 2020;26(12):1503–1508. doi:10.1089/mdr.2019.0461
   PubMed Web of Science ®Google Scholar